Gegen Shihu Formula
Natural health product licensed in Canada
- Licence holder
- Canadian Phytopharmaceuticals Corporation
- NPN or DIN-HM
- 80059184
- Status
- Active licence
- Licence date
- 25 March 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Combination of Traditional Chinese Medicinal Ingredients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a healthcare practitioner if you are taking other medications. Keep out of reach of children. Consult a health care practitioner if symptoms persist or worsen. If symptoms develop, discontinue use and consult a health care practitioner. If you are pregnant or breastfeeding, do not use this product. Consult a health care practitioner prior to use if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine). Consult a health care practitioner prior to use if you have cardiovascular condition and/or taking medication for cardiovascular condition. Consult a health care practitioner prior to use due to possible estrogenic effect. For women only: Do not use if you currently have or previously had breast cancer or if you have a predisposition to breast cancer such as abnormal mammogram and/or biopsy, or a family member with a breast cancer. Consult a health care practitioner prior to use if you have a personal history of hormonal or gynecological disease including ovarian cancer, endometriosis and/or uterine fibroids. Before use, ensure that you are up-to-date on appointed clinical tests such as mammograms and endometrial ultrasounds/biopsies. Discontinue use and consult a health care practitioner if you experience breast pain, discomfort, soreness and/or tenderness, abnormal uterine bleeding including spotting and/or recurrence of menstruation in post-menopausal women. Consult a health care practitioner prior to use if you are taking hormone replacement therapy.
Source
Official Health Canada record, licence 80059184
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.